These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14749172)

  • 1. Hyperammonemia: elevated ammonia levels in multiple myeloma.
    Holahan JR
    Am J Med; 2004 Feb; 116(3):210-1. PubMed ID: 14749172
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.
    Ikewaki J; Ogata M; Imamura T; Kohno K; Nakayama T; Kadota J
    Leuk Lymphoma; 2009 Apr; 50(4):667-9. PubMed ID: 19373670
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperammonemia and encephalopathy in patients with multiple myeloma.
    Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G
    Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperammonemic encephalopathy associated with multiple myeloma.
    López-Blanco R; de Fuenmayor-Fernández de la Hoz CP; González de la Aleja J; Martínez-Sánchez P; Ruiz-Morales J
    Neurologia; 2017 Jun; 32(5):339-341. PubMed ID: 26541697
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.
    Pham A; Reagan JL; Castillo JJ
    Leuk Res; 2013 Oct; 37(10):1229-32. PubMed ID: 23932549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma with a variant Burkitt-type translocation, t(2;8)(p12;q24), associated with hyperammonemia.
    Yamamoto Y; Konoike Y; Nakamine H; Nakamura S; Morii T; Kimura H
    Intern Med; 2009; 48(14):1239-42. PubMed ID: 19602793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemic encephalopathy in multiple myeloma.
    Kwan L; Wang C; Levitt L
    N Engl J Med; 2002 May; 346(21):1674-5. PubMed ID: 12024007
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperammonemic encephalopathy in multiple myeloma.
    Furer V; Heyd J
    Isr Med Assoc J; 2007 Jul; 9(7):557-9. PubMed ID: 17710792
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperammonaemic encephalopathy and severe metabolic acidosis in a patient with chronic renal insufficiency years after ureterosigmoidostomy.
    Hampel DJ; Stoll J; Nibbe L; Gollasch M
    Nephrol Dial Transplant; 2007 Sep; 22(9):2713-9. PubMed ID: 17556426
    [No Abstract]   [Full Text] [Related]  

  • 11. [Refractory multiple myeloma with impaired consciousness accompanied by hyperammonemia and leukoencephalopathy-like findings].
    Konuma H; Aota Y; Udagawa S; Honda T; Okuda Y; Iwai T; Sujino H; Takahashi M; Kitagawa N; Gotoh A
    Rinsho Ketsueki; 2020; 61(3):234-239. PubMed ID: 32224583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amino acid disturbance in multiple myeloma with hyperammonemia.
    Matsuzaki H; Hata H; Sonoki T; Matsuno F; Kuribayashi N; Yoshida M; Nagasaki A; Murata H; Fujiyama S; Takatsuki K
    Int J Hematol; 1995 Apr; 61(3):131-7. PubMed ID: 7599324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemia: an unusual presenting feature of multiple myeloma.
    Shah AS; Shetty N; Jaiswal S; Mehta BC
    Indian J Med Sci; 2005 Jan; 59(1):24-7. PubMed ID: 15681889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.
    Lora-Tamayo J; Palom X; Sarrá J; Gasch O; Isern V; Fernández de Sevilla A; Pujol R
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):363-9. PubMed ID: 19064403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of hyperammonemia presented in a patient with multiple myeloma].
    Sjölund I; Kragsbjerg P
    Lakartidningen; 2021 Jun; 118():. PubMed ID: 34151998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsing encephalopathy secondary to non-hepatic hyper-ammonemia.
    Peter JV; Zimmermann AT
    J Postgrad Med; 2006; 52(2):157-8. PubMed ID: 16679692
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple Myeloma with Hyperammonemia Treated with Novel Agents: A Case Series of Three Patients.
    Nakamura H; Takada K; Murase K; Ikeda H; Iyama S; Manabe T; Kobune M
    Intern Med; 2023 Mar; 62(5):775-778. PubMed ID: 35871579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological study of multiple myeloma associated with hyperammonemia].
    Fujii S; Fukuda S; Sezaki T; Murakami M
    Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.
    Nott L; Price TJ; Pittman K; Patterson K; Young R; Fletcher J
    Intern Med J; 2008 Oct; 38(10):800-3. PubMed ID: 19143880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.